Provider review

MyDrHank review

Publishes a price before the quiz — and it is the twelve-month rate

Sermorelin costs $199 a month bought a month at a time, a figure the site renders on no page; the $137 it advertises everywhere is $1,644 paid up front, and the same $137 prices its NAD+ nasal spray.

Verified August 2026Partner

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

Visit MyDrHank

On this page

The verdict

MyDrHank does the thing most of this board will not: it prints a dollar figure on a public page before asking you a single intake question. The problem is which figure. Sermorelin has a four-rung term ladder — $199 a month, $507 a quarter, $913 for six months, $1,644 for a year — and the one piece of code on the site that renders a per-month price takes the cheapest rung of that ladder, so "Starting at $137/month" is the twelve-month prepay rate by construction, on every page, for every product. The $199 you would actually pay buying one month at a time is displayed nowhere. Two details make that harder to read as an oversight: $137 is not a sermorelin price at all — the NAD+ nasal spray carries the identical ladder down to the dollar — and the fine print directly under the $137 concedes that "final pricing depends on the protocol and dose prescribed" anyway. For an athlete there is a separate problem the price never touches: sermorelin is a GHRH analog, prohibited at all times in tested sport, and this lander markets it for lean muscle and faster recovery without mentioning sport, testing or anti-doping once.

MyDrHank appears on our recovery-peptide provider hub and our sermorelin provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

You already know you want twelve months of sermorelin and you can put $1,644 down today — that is the one buyer for whom the advertised price is the real one
You want to see a number before handing over an email address and walking a medical questionnaire
You want one login across several protocols: the same account carries GLP-1, NAD+, hair, sexual health and strength lines
You are not drug-tested by any sporting body, and the WADA status of a GH secretagogue is genuinely irrelevant to you

Look elsewhere if

You want to buy a month, try it, and stop — that costs $199, which is 45% above the advertised figure and appears on no page of the site
You compete under a WADA code, or in any tested federation: sermorelin is class S2, prohibited at all times, and this provider's marketing never raises it
You want the price you were quoted to survive a dose increase — the lander's own fine print says it depends on the protocol and dose prescribed
You want to confirm your state is served before paying: no served-states list is published anywhere on the consumer site
You want to know which pharmacy compounds your vial, or under which section of the Act it operates

What it actually costs

What they advertise

"Starting at $137" per month, pinned in the sermorelin lander's sticky nav as "Sermorelin Therapy · Starting at $137" and repeated on the product card. Immediately beneath it, in 11px type: "Final pricing depends on the protocol and dose prescribed."

What you actually pay, month to month

$199/month buying one month at a time. The full ladder is $199 monthly, $507 quarterly ($169/mo), $913 for six months ($152/mo), and $1,644 for a year ($137/mo) — so the advertised number is the last rung, and the first rung is rendered on no page of the site.

The commitment trap

The advertised price is the twelve-month prepay rate, and that is enforced in code rather than buried in a footnote. The single component that renders a per-month figure reduces the term ladder to its minimum — `t.reduce((n,r) => r.num < n.num ? r : n).raw`, rendered as "From {…}/mo" — and there are exactly two render paths for a per-month price in the whole 689 KB bundle, both of them that reduce. So every "from $X/mo" MyDrHank displays anywhere, on any product, is a twelve-month commitment rate by construction, and no page can display the month-to-month one. A second tell that $137 is a platform tier rather than a sermorelin price: the NAD+ nasal spray carries the identical $199 / $507 / $913 / $1,644 ladder.

Money you will meet later

$1,644 charged up front is the actual cost of the advertised $137/month — the per-month figure is the division, not the bill
The free physician consultation is a promotion: the lander's banner reads "Limited time — Free physician consultation with your first order", and no standing consult price is published for a later order
A dose or protocol change is a price change, per the site's own fine print — no dose-price schedule is published
Shipping is free and stated as such; no supplies charge is mentioned either way

Checked live on MyDrHank's own site at https://mydrhank.com/sermorelin/lp/v2 in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what MyDrHank bundles in, and what it does not.

Clinician consult

Advertised as free, but as a limited-time promotion attached to…

the first order — the lander's top banner says "Limited time — Free physician consultation with your first order." What a consult costs once that promotion ends, or on any later order, is not published.

Bloodwork / labs

Not required and not offered

"No bloodwork required to start" appears in the intake step and again in the FAQ. That is convenient, and it also means nobody measures an IGF-1 level before, during or after treatment.

Follow-ups and dose changes

A U

S. board-certified clinician is stated to review the intake within 24 hours and build a protocol. No follow-up or dose-change fee is published — but the price itself is stated to depend on the protocol and dose prescribed, so a dose conversation is a pricing conversation here.

Human support

The prescribing clinician and nothing else

No coach, nurse or dietitian is offered anywhere on the sermorelin line.

Injection supplies

Not mentioned

The protocol is a subcutaneous injection at bedtime five days a week, so confirm whether syringes, needles and swabs are in the box before you order.

Shipping

Free, in plain packaging

— "shipped free from a licensed U.S. compounding pharmacy", per the lander's own third step.

Pharmacy, labs and oversight

The pharmacy

Not named and not designated, and the site gives two different descriptions of it on the same page. The sermorelin product's disclaimer says "Compounded in an FDA-registered U.S. pharmacy"; the delivery step three screens above says "a licensed U.S. compounding pharmacy." Registration is not approval, and a 503A pharmacy is state-licensed rather than FDA-registered, so neither phrase resolves to a facility type. The one place "503A" appears in the entire bundle is a GLP-1 footnote — "Compounded semaglutide and tirzepatide are prepared by FDA-registered outsourcing or 503A pharmacies" — which is about other drugs and hedges between two mutually exclusive categories even for them. A LegitScript seal in the footer links out to LegitScript's own verifier, which is a certification claim rather than a facility-type disclosure. Three pharmacy names carried by older research on this company — Dunklau Pharmacy Holdings, InnovaScript and PCM Venture I Pharmacy — have zero occurrences on the site or in its bundle today, so we do not credit a disclosure we cannot see.

Oversight

Advertised as free, but as a limited-time promotion attached to the first order — the lander's top banner says "Limited time — Free physician consultation with your first order." What a consult costs once that promotion ends, or on any later order, is not published. A U.S. board-certified clinician is stated to review the intake within 24 hours and build a protocol. No follow-up or dose-change fee is published — but the price itself is stated to depend on the protocol and dose prescribed, so a dose conversation is a pricing conversation here.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

No served-states list is published anywhere on the consumer site — none of the six states its affiliate terms exclude are so much as named in the bundle. Those terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia, which is a list a customer can only find by reading the affiliate program rather than the store. Treat nationwide coverage as an assumption and confirm before you pay.

The honest cons

The part they would rather you skipped

The advertised price cannot be the price you pay unless you commit to a year, and that is a property of the software rather than a disclosure failure someone could fix with a footnote. MyDrHank's price display reduces each product's term ladder to its cheapest rung before rendering it, so "Starting at $137/month" is the $1,644-up-front rate by construction — and the $199 month-to-month rung, which sits right there in the product's own pricing data, reaches no page on the site. The same architecture prices the NAD+ nasal spray at the same $137, which is how you can tell the number describes a commitment tier rather than sermorelin. The funnel also advertises a price that exists at no tier at all: a GLP-1 footnote reads "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide," and no tirzepatide rung costs $200 — the cheapest is $240 — while the $171 is the ORAL product's yearly rate, not the injectable's, whose yearly rate is $178. The same FAQ calls a twelve-month prepay a plan with "no contract." Separately, and more directly relevant to anyone reading this site: sermorelin is a growth-hormone-releasing-hormone analog, prohibited at all times under WADA class S2, and the words sport, athlete, tested, banned and doping appear nowhere in this company's application bundle while its sermorelin page merchandises the drug under "Growth & Recovery" for "lean muscle growth and faster recovery." Its mechanism section attributes a "~50% increase in IGF-1 levels" to a citation string that runs two different papers together — an author and a trial description, then a second author, a journal and a year — with no link to either, so a reader cannot check the headline stat against a specific study. Compounded sermorelin is not an FDA-approved product, and the recovery and body-composition outcomes it is marketed for are not established in healthy trained adults; our own evidence pages, linked below, set out what the trials do and do not support.

Every "from $X/mo" the site displays is the twelve-month prepay rung, on every product — the display takes the minimum of the term ladder before rendering it
The $199 month-to-month rate for sermorelin is in the product's own data and reaches no page of the site
$137 is a platform commitment tier, not a sermorelin price: the NAD+ nasal spray carries the identical $199 / $507 / $913 / $1,644 ladder
The advertised figure is disclaimed in its own fine print — "final pricing depends on the protocol and dose prescribed"
The "free physician consultation" is a limited-time first-order promotion, not a standing inclusion, and no consult price is published for later orders
A GLP-1 footnote advertises "$200/mo for compounded tirzepatide," a figure purchasable at no tier — the cheapest tirzepatide rung is $240
No served-states list on any consumer page; the affiliate terms exclude six states a customer would never see
No pharmacy is named, and the page describes its own pharmacy two different ways within three screens
Markets a WADA class S2 substance for muscle and recovery without mentioning sport, testing or anti-doping anywhere
The "~50% increase in IGF-1" headline is sourced to a citation string that mashes two separate papers together with no link to either

None of this is unique to MyDrHank — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.

How it compares

The providers we rank on our sermorelin provider ranking — the most specific board MyDrHank sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the verdict.

13 more providers rank on our sermorelin provider ranking — see the full ranking. Every provider we review →

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

The evidence

The tools

Visit MyDrHank All provider reviews

Facts on this page reflect MyDrHank's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MyDrHank's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.